Table 2.
Outcomes reported in the included studies
| Author, year | Group | Variceal bleeding (n/N) | All-cause mortality (n/N) | Bleeding-related mortality (n/N) | Adverse events (n/N) |
|---|---|---|---|---|---|
|
| |||||
| Abd Elrahim et al,18 2018 | C | 13/84 | NR | NR | 12/84 |
| EBL | 9/88 | NR | NR | 5/84 | |
| Stanley et al,20 2014 | C | 12/33 | 9/33 | 5/33 | 19/33 |
| EBL | 11/31 | 16/31 | 1/31 | 18/31 | |
| Shah et al,17 2014 | C | 7/82 | 16/82 | 4/82 | 50/82 |
| EBL | 6/86 | 11/86 | 4/86 | 75/86 | |
| Tripathi et al,21 2009 | C | 7/77 | 20/77 | 2/77 | 10/77 |
| EBL | 14/75 | 16/75 | 2/75 | 6/75 | |
| Elnadry et al,13 2010 | C | 2/20 | NR | NR | 13/20 |
| EBL | 2/20 | NR | NR | 5/20 | |
| Ahmad et al,19 2012 | C | 2/25 | NR | NR | NR |
| EBL | 3/25 | NR | NR | NR | |
| Reiberger et al,16 2013 | C | 3/38 | 4/38 | 1/38 | NR |
| EBL | 7/29 | 9/29 | 5/29 | NR | |
Abbreviations: C, carvedilol; EBL, endoscopic band ligation; NR, not reported.